“Despite organizations’ large investments in security, email fraud continues to rise,” the report authors wrote. “Cybercriminals are growing more advanced. And attacks are evading traditional security tools, leaving people as the last line of defense.”
Read more here.
Medical imaging technologies and machine learning will support a new generation of tools that can personalize treatments and improve outcomes for patients.
Read more here.
CEO Larry Culp acknowledged as much in a post-earnings conference call, stating, “We expect to monetize just up to under 50 percent of our health-care business,” adding that the unit “continues to prepare for public company separation, and that is progressing very well,”
Read more here.
When speaking about the growth of the Image-Guided Therapy businesses, Frans van Houten, CEO of Royal Philips, said in a statement. “To strengthen our leadership in this fast-growing market, we have significantly invested in our R&D programs, which resulted in the launch of the very successful Azurion next-generation image-guided therapy platform, and the acquisitions of Volcano, Spectranetics and, most recently, EPD Solutions, which enabled the expansion into smart devices such as diagnostic and therapeutic catheters.”
Read more here.